Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Vulvar Neoplasms × Bleomycin × Clear all

Phase

Status

Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 2 Vulvar Neoplasms 1 Teratoma 1 Skin Neoplasms 1 Seminoma 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1 Neoplasms, Germ Cell and Embryonal 1 Gynecological Cancers 1 Endodermal Sinus Tumor 1 Desmoid Tumors 1 Carcinoma, Embryonal 1

Interventions

Cisplatin 2 Carboplatin 2 trastuzumab deruxtecan 1 pembrolizumab 1 liposomal doxorubicin 1 lenvatinib 1 fludarabine 1 dostarlimab 1 belzutifan 1 aldesleukin 1 Vaccines, Synthetic 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Specimen Handling 1 Radiation 1 Platinum 1 Papillomavirus Vaccines 1 Paclitaxel 1 Nelfinavir 1 Imiquimod 1 Hysterectomy 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Heavy Ion Radiotherapy 1 Gemcitabine 1 Electrochemotherapy 1 Drug Therapy 1 Doxorubicin 1 Dehydroepiandrosterone 1 Cyclophosphamide 1 CA-125 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05395962 2022-05-27

Elechtra

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase 2 Recruiting

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡